GB0712302D0 - Chrondroitinase polypeptides - Google Patents

Chrondroitinase polypeptides

Info

Publication number
GB0712302D0
GB0712302D0 GBGB0712302.9A GB0712302A GB0712302D0 GB 0712302 D0 GB0712302 D0 GB 0712302D0 GB 0712302 A GB0712302 A GB 0712302A GB 0712302 D0 GB0712302 D0 GB 0712302D0
Authority
GB
United Kingdom
Prior art keywords
chrondroitinase
polypeptides
chrondroitinase polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0712302.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cambridge Enterprise Ltd
Original Assignee
Cambridge Enterprise Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge Enterprise Ltd filed Critical Cambridge Enterprise Ltd
Priority to GBGB0712302.9A priority Critical patent/GB0712302D0/en
Publication of GB0712302D0 publication Critical patent/GB0712302D0/en
Priority to PCT/GB2008/002143 priority patent/WO2009001058A1/en
Priority to GB1002589A priority patent/GB2465307A/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/51—Lyases (4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y402/00—Carbon-oxygen lyases (4.2)
    • C12Y402/02—Carbon-oxygen lyases (4.2) acting on polysaccharides (4.2.2)
    • C12Y402/02004—Chondroitin ABC lyase (4.2.2.4), i.e. chondroitinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GBGB0712302.9A 2007-06-22 2007-06-22 Chrondroitinase polypeptides Ceased GB0712302D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0712302.9A GB0712302D0 (en) 2007-06-22 2007-06-22 Chrondroitinase polypeptides
PCT/GB2008/002143 WO2009001058A1 (en) 2007-06-22 2008-06-23 Modified chondroitinase polypeptides
GB1002589A GB2465307A (en) 2007-06-22 2008-06-23 Modified chondroitinase polypeptides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0712302.9A GB0712302D0 (en) 2007-06-22 2007-06-22 Chrondroitinase polypeptides

Publications (1)

Publication Number Publication Date
GB0712302D0 true GB0712302D0 (en) 2007-08-01

Family

ID=38352881

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB0712302.9A Ceased GB0712302D0 (en) 2007-06-22 2007-06-22 Chrondroitinase polypeptides
GB1002589A Withdrawn GB2465307A (en) 2007-06-22 2008-06-23 Modified chondroitinase polypeptides

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB1002589A Withdrawn GB2465307A (en) 2007-06-22 2008-06-23 Modified chondroitinase polypeptides

Country Status (2)

Country Link
GB (2) GB0712302D0 (en)
WO (1) WO2009001058A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014171826A1 (en) * 2013-04-17 2014-10-23 Stichting Vu-Vumc Treatment of cognitive impairment in depressive disorders
CN108795917A (en) * 2018-07-18 2018-11-13 北京电子科技职业学院 A kind of circumscribed-type chondrosulphatase AC and the preparation method and application thereof
CN116790571A (en) * 2023-05-17 2023-09-22 西南大学 High-thermal-stability endo-alginic acid lyase mutant based on rational design modification and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3419811B2 (en) * 1993-02-24 2003-06-23 マルハ株式会社 Chondroitinase gene
EP1532241B1 (en) * 2002-06-03 2010-09-15 Massachusetts Institute Of Technology Rationally designed polysaccharide lyases derived from chondroitinase b
WO2005087920A2 (en) * 2004-03-10 2005-09-22 Massachusetts Institute Of Technology Recombinant chondroitinase abc i and uses thereof

Also Published As

Publication number Publication date
GB201002589D0 (en) 2010-03-31
GB2465307A (en) 2010-05-19
WO2009001058A1 (en) 2008-12-31

Similar Documents

Publication Publication Date Title
GB0721686D0 (en) Polypeptides
IL221062A0 (en) Stitched polypeptides
DE602008005470D1 (en) Imidazopyridinone
EP2160187A4 (en) Spiroindalones
AP2010005314A0 (en) Nanodispersian
EP2211752A4 (en) Biopulp
ZA201000283B (en) Reinigung pegylierter polypeptide
GB0723712D0 (en) Peptides
EP2123666A4 (en) Peptide
GB0715132D0 (en) Tissue-adhesive materials
GB0623539D0 (en) Polypeptides
GB0712302D0 (en) Chrondroitinase polypeptides
GB0809659D0 (en) Polypeptides
GB0703945D0 (en) Peptide
GB0713587D0 (en) Insulaitng materials
DE602008004135D1 (en) Triphenylmethan- und xanthenpigmente
AU3702P (en) DarwinGold Dianella ensifolia
AU3646P (en) TAS300 Dianella tasmanica
AU3595P (en) Goldust Strobilanthes anisophyllus
AU3606P (en) Jaywick xTriticosecale
AU3613P (en) LS005A01 Leucospermum cuneiforme
AU3642P (en) TAS100 Dianella tasmanica
AU3952P (en) FLOCHRDEF Chrysocephalum apiculatum
GB0705251D0 (en) Peptides
GB0707626D0 (en) Peptides

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)